Source: Health Products and Food Branch (CA) Revision Year: 2021
XYLOCARD Lidocaine hydrochloride
Solution, 20 mg/mL, Intravenous.
Table 2. Dosage Forms, Strengths, Composition and Packaging:
| Route of Administration | Dosage Form/Strength/Composition | Non-medicinal Ingredients |
|---|---|---|
| Intravenous | 20 mg/mL | Sodium chloride, sodium hydroxide and/or hydrochloric acid, water for injection |
XYLOCARD 100 mg is available in a 5 mL glass ampoule (contains 20 mg/mL, a 2% solution). Each carton contains 10 ampoules with a leaflet.
See DOSAGE AND ADMINISTRATION section for instructions regarding preparation of solutions for continuous intravenous infusion.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Aspen Pharmacare Canada Inc., 8 – 1155 North Service Road West, Oakville, ON, L6M 3E3 246218 |
Date of approval:
December 31, 1974 May 21, 2021 |
| Drug | Countries | |
|---|---|---|
| XYLOCARD | Canada, France |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
